Dow Up 1.30% Nasdaq Up 0.37%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
36.15 0.27(0.75%) Oct 30, 4:00PM EDT
|After Hours : 36.15 Up 0.00 (0.01%) Oct 30, 4:37PM EDT
Prev Close:35.88
Open:36.38
Bid:31.80 x 200
Ask:39.00 x 100
1y Target Est:43.23
Beta:1.6
Next Earnings Date:N/A
Day's Range:34.52 - 36.41
52wk Range:27.51 - 39.95
Volume:827,181
Avg Vol (3m):712,151
Market Cap:1.48B
P/E (ttm):80.87
EPS (ttm):0.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACOR

Comparison

Symbol% ChgMkt Cap
ACORUp 0.75%1.48B
BIIB75.81B
TEVA48.21B

Key Statistics

Forward P/E (1 yr):106.32
P/S (ttm):4.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.18
Quarterly EPS Est (Dec-14) :0.00
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):4.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback